Eric Carpentier, Ph.D.
Affiliations: | 2011 | Université de Montréal, Montréal, Canada |
Google:
"Eric Carpentier"Mean distance: 17.4 (cluster 11) | S | N | B | C | P |
Parents
Sign in to add mentor| Michel Bouvier | grad student | 2011 | Université de Montréal | |
| (Consequences fonctionnelles de mutations affectant le recepteur de la vasopressine de type 2 et implications therapeutiques.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Mancini AD, Bertrand G, Vivot K, et al. (2015) β-Arrestin Recruitment and Biased Agonism at Free Fatty Acid Receptor 1. The Journal of Biological Chemistry. 290: 21131-40 |
| Ceraudo E, Galanth C, Carpentier E, et al. (2014) Biased signaling favoring gi over β-arrestin promoted by an apelin fragment lacking the C-terminal phenylalanine. The Journal of Biological Chemistry. 289: 24599-610 |
| Mancini A, Bertrand G, Vivot K, et al. (2014) Beta-Arrestin 2 Recruitment and Biased Agonism at the Free Fatty Acid Receptor GPR40 Canadian Journal of Diabetes. 38: S66 |
| Mancini AD, Carpentier É, Bouvier M, et al. (2013) TAK-875 is a Partial Agonist of the Free Fatty Acid Receptor GPR40 Canadian Journal of Diabetes. 37: S59 |
| Carpentier E, Greenbaum LA, Rochdi D, et al. (2012) Identification and characterization of an activating F229V substitution in the V2 vasopressin receptor in an infant with NSIAD. Journal of the American Society of Nephrology : Jasn. 23: 1635-40 |
| Rochdi MD, Vargas GA, Carpentier E, et al. (2010) Functional characterization of vasopressin type 2 receptor substitutions (R137H/C/L) leading to nephrogenic diabetes insipidus and nephrogenic syndrome of inappropriate antidiuresis: implications for treatments. Molecular Pharmacology. 77: 836-45 |
| Bockenhauer D, Carpentier E, Rochdi D, et al. (2010) Vasopressin type 2 receptor V88M mutation: molecular basis of partial and complete nephrogenic diabetes insipidus. Nephron. Physiology. 114: p1-10 |
| Carpentier E, Lebesgue D, Kamen AA, et al. (2001) Increased production of active human beta(2)-adrenergic/G(alphas) fusion receptor in Sf-9 cells using nutrient limiting conditions. Protein Expression and Purification. 23: 66-74 |